Literature DB >> 8243616

The yield of bronchoalveolar lavage in the etiological diagnosis of pneumonia in leukemia and lymphoma patients.

R Marra, L Pajano, G Pagliari, L Frigiera, S Storti, G Morace, F Ardito, G Leone.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 8243616     DOI: 10.1111/j.1600-0609.1993.tb00641.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  5 in total

1.  Role of bronchoalveolar lavage in immunocompromised patients with pneumonia treated with a broad spectrum antibiotic and antifungal regimen.

Authors:  I A Hohenadel; M Kiworr; R Genitsariotis; D Zeidler; J Lorenz
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

2.  Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective Treatment.

Authors:  Susanne Ghandili; Philipp H von Kroge; Marcel Simon; Frank O Henes; Holger Rohde; Armin Hoffmann; Nick Benjamin Lindeman; Carsten Bokemeyer; Walter Fiedler; Franziska Modemann
Journal:  Cancers (Basel)       Date:  2022-06-02       Impact factor: 6.575

3.  Pulmonary fungal infections in patients with hematological malignancies--diagnostic approaches.

Authors:  M von Eiff; M Zühlsdorf; N Roos; M Hesse; R Schulten; J van de Loo
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

4.  Bacterial yield from quantitative cultures of bronchoalveolar lavage fluid in patients with pneumonia on antimicrobial therapy.

Authors:  Eun Sun Kim; Eui-Chong Kim; Sang-Min Lee; Seok-Chul Yang; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Jae-Joon Yim
Journal:  Korean J Intern Med       Date:  2012-05-31       Impact factor: 2.884

5.  The Diagnostic Yield, Safety, and Impact of Flexible Bronchoscopy in Non-HIV Immunocompromised Critically Ill Patients in the Intensive Care Unit.

Authors:  Mazen O Al-Qadi; Rodrigo Cartin-Ceba; Rahul Kashyap; Sumanjit Kaur; Steve G Peters
Journal:  Lung       Date:  2018-10-10       Impact factor: 2.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.